News

Cluster 3 Cybersecurity calls now open for submission

Published on | 1 month ago

Programmes
Civil Security

The new call for proposals under the Cluster 3 Cybersecurity destination, originally announced to open on 3 March is now open for submission

The call with overall indicative budget of up to EUR 56.2 million covers the following topics: 

  • Approaches and tools for security in software and hardware development and assessment (HORIZON-CL3-2026-02-CS-ECCC-01, EUR 20 million)
  • Enhancing the Security, Privacy and Robustness of AI Models and Systems (SecureAI) (HORIZON-CL3-2026-02-CS-ECCC-02, Budget EUR 21.2 million)
  • Advanced cryptographic schemes and High-Assurance high-speed cryptographic implementations (HORIZON-CL3-2026-02-CS-ECCC-03, Budget EUR 15 million)

For all 3 topics from above, proposals can be submitted until 15 September 2026 17:00 CET. The eligibility criteria and all relevant call documents are available on the Funding and Tenders portal at this link.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1871 articles available search in articles 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.